Virtual consulting · Worldwide
NeuciteConsultingRequest a quote

Clinical evaluation report literature reviews that can be reproduced

A protocol, search logs, dual screening, appraisal and state of the art for your MDR clinical evaluation report, so a notified body reviewer can rerun every search and see why each study was kept or excluded.

The literature review is where most clinical evaluations are challenged

Under the EU MDR, every device needs a clinical evaluation that follows Article 61 and Annex XIV. The clinical evaluation report summarizes that work and the conclusions on safety, performance and benefit-risk. For many devices, published literature carries much of the evidence. That makes the literature review the part reviewers test hardest. They ask how the search was built, who screened it and why each paper counts.

We treat the review as a documented method rather than a reading list. A protocol fixes the questions, databases, search strings and selection criteria before searching starts. Two reviewers screen records against those criteria. Each included study is appraised for relevance and quality, and data are extracted into structured tables. The result is a review that can be rerun and updated.

Methodology follows MEDDEV 2.7/1 rev 4, still a widely used reference, together with current MDCG guidance. The state of the art section defines the clinical background, alternative treatments and benchmarks. Those benchmarks then inform the acceptance criteria for your device's safety and performance. Unlike generic literature review services, the whole method is built around your device's claims and risks.

What the literature work delivers

Each item can be delivered alone or folded into your clinical evaluation report.

01

Literature search protocol

Review questions, databases, search strings, date limits, and inclusion and exclusion criteria. It is written and agreed before searching, so the method is fixed and auditable.

02

Search and screening record

Search logs with dates and hit counts, deduplication, title and abstract screening, full-text decisions with reasons, and a flow diagram showing how records were selected.

03

Appraisal and data tables

Each included study is weighted for suitability and contribution to the evidence. Outcomes, adverse events, follow-up and population details are extracted into consistent tables for comparison.

04

State of the art analysis

The clinical condition, current standard of care, alternative therapies, and published performance and safety benchmarks. These benchmarks then inform the acceptance criteria for evaluating your device.

05

Equivalence assessment

A side-by-side review of technical, biological and clinical characteristics against MDR and MDCG criteria. It also checks whether you hold the data access that equivalence requires.

06

Report sections and gap list

Drafted literature, state of the art and clinical data sections for the report. A gap list shows where PMCF activity or new data may be needed.

From question to defensible evidence

Scope and protocol

We review your intended purpose, claims, classification and existing file. We then agree the review questions and write the search protocol, so the method is set before any results are seen.

Search, screen and appraise

We run the searches, record every step, and screen with two reviewers. Included studies are appraised and extracted. Disagreements are resolved and logged, so the selection can be traced later.

Analyze and write

We analyze the data against the state of the art and your safety and performance claims. We draft the report sections and give you a clear list of remaining evidence gaps.

How clinical evaluation work typically looks

A

Wound care device manufacturer

An old literature review nobody can reproduce

Situation
A dressing's technical file contains a literature review written years ago. There is no protocol, no search log and no record of why papers were excluded. A recertification under the MDR is approaching. The team needs a review that will stand up to scrutiny.
How we advise
We would start a fresh protocol rather than patch the old review. Questions would cover safety, performance and the state of the art in wound management. We would search several databases, screen in duplicate and appraise each study for relevance to the dressing's materials and indications. Earlier references would be rechecked under the new criteria, not carried over by default.
What you receive
A protocol, full search and screening records, appraisal tables, a state of the art section and updated literature sections for the clinical evaluation report.
B

Established device manufacturer

A legacy device with little recent clinical data

Situation
A device has been sold for many years under the old directive. Most clinical support comes from studies of similar devices and from market experience. The company wants to know whether an equivalence route is still realistic under the MDR.
How we advise
We would compare the device with each candidate equivalent across technical, biological and clinical characteristics. Under the MDR, equivalence is restrictive and needs sufficient access to the other device's data. For implantable and class III devices, relying on another manufacturer's device instead of a clinical investigation also needs a contract giving full, ongoing access to its technical documentation. We would state plainly where equivalence holds, where it fails, and what could close the gap.
What you receive
An equivalence assessment, a summary of usable evidence on the device itself, and an evidence gap analysis with options such as PMCF studies or registry data.
C

Medical device start-up

An auditor challenges how the literature was searched

Situation
A notified body review has raised findings on the literature search. The reviewer could not reproduce the results and questioned the exclusion of several studies. The team has a fixed response deadline and limited in-house methodology support.
How we advise
We would read each finding and map it to a gap in method or documentation. We would then rebuild the search under a written protocol and rerun screening with recorded reasons. Where the findings concern specific studies, we would reassess them openly. The response would explain what changed and why, with evidence attached.
What you receive
A rebuilt, documented literature review, revised report sections, and a point-by-point draft response to the findings for your regulatory team to finalize.

Illustrative scenarios. Each is a composite of common client situations, not a specific engagement.

Frequently asked questions

Do you write the whole clinical evaluation report?

We can draft the full report, or only the literature, state of the art and data analysis sections. Either way, the clinical evaluation report remains your document. It is signed off by evaluators with suitable qualifications who declare their interests. We supply the methodology and the literature work alongside your evaluators.

Which databases do you search?

The choice depends on the device and the questions. Typical sources include PubMed or MEDLINE, Embase and the Cochrane Library. We often add clinical trial registries, safety databases and relevant society guidance. The protocol states each source and why it was chosen. Search strings and dates are recorded so anyone can rerun them.

Is MEDDEV 2.7/1 rev 4 still relevant under the MDR?

It was written for the directives, but its methodology for literature search, appraisal and analysis remains a common reference. Notified bodies often still expect to see it applied. We combine it with MDR requirements and current MDCG guidance, for example on equivalence and on sufficient clinical evidence for legacy devices.

What do you need from us to start?

We need the intended purpose, device description, claims, risk management file and any existing clinical evaluation. Post-market data, complaints and PMCF results help too. If you have earlier searches, we will review them, but we will not reuse them without checking their method.

How long does a clinical evaluation literature review take?

The main drivers are the breadth of questions, the volume of literature and the number of devices compared. A focused review on a well-defined device may take several weeks. A broad state of the art across several indications takes longer. We give a timeline after scoping, once we have seen your existing file.

Can you promise notified body approval?

No one can promise that. Decisions rest with the notified body, and clinical evidence is only one part of the assessment. What we can do is make the method transparent, the evidence traceable and the conclusions proportionate to the data. That reduces avoidable questions and makes any questions easier to answer.

Find out what your literature review needs

Share your device’s intended purpose and the current review. We’ll follow up by email about the claims and clinical file, then send a written quote for the review or rebuild.

Neucite Consulting prepares clinical evidence and documentation; the manufacturer remains responsible for the clinical evaluation, and conformity decisions rest with notified bodies and authorities.